Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
RLS Global - Naventus Life Science Summit - Karin Fischer, CEO, RLS Global
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
RLS Global - Naventus Life Science Summit
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:00:00
Soligenix CEO Chris Schaber highlights the company's major milestones - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:10:00
Kenichi Hori, CEO, Manuel Pangilinan, MPIC Chairman, and other executives outline strategic plans at Metro Pacific Investments Corporation.
00:10:00
We back ambitious founders who actively try change the firm to company|Kenneth Chenault,Chairman and Managing Director,General Catalyst
00:10:00
8Common (8CO) Chairman, Nic Lim and CEO, Nick Gonios | Kah Wui “Nic” Lim, MD, 8Common Ltd8CO:ASX
00:10:00
The Quincy Institute and America's Foreign Policy|Andrew Bacevich,Professor,Boston University
00:10:00
Maximizing Returns with Dollar-Cost Averaging During Market Dips | Ben Smith, Founder, Cove Financial Planning, LLC.
00:10:00
Value Investing in a Changing World: Adapting Strategies for Sustainable Success | Dato’ Seri Cheah Cheng Hye, Co-Chairman , Value Partners .
00:00:00
Jesse D. Bracamonte, D.O.
00:10:00
BoxGroup: Investing in Tomorrow's Tech Titans cause they focus on tech|Adam Rothenburg,Partner,BoxGroup
00:10:00
Updates on OvaSuite®, OvaWatchSM, and EndoCheckTM Discussed in Fireside Chat with CEO| Nicole Sandford, CEO, Aspira Women's Health Inc.
00:10:00
Ascom Network Testing highlights iBuildNet solution | Nicolas Vanden Abeele, CEO, Ascom Holding AGAH2.N:BER
00:00:00
C4X Discovery CEO welcomes start of Indivior trial and outlines new coronavirus venture -Clive Dix BSc PhD HonFBPhS, Interim Executive Chairman & CEO, C4X Discovery Holding